Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04007757 · ClinicalTrials.gov registry record

Recovery and Outcomes From Stroke

A clinical trial of Intracerebral Hemorrhage, sponsored by State University of New York at Buffalo.

Completed
Registry status
500
Enrollment target
8
Study locations

NCT04007757: Completed study of Intracerebral Hemorrhage, sponsored by State University of New York at Buffalo.

NCT04007757 is a study of Intracerebral Hemorrhage that has completed, run by State University of New York at Buffalo. The registered enrollment target is 500 participants, below the 1,090-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (54% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04007757, a study of Intracerebral Hemorrhage, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
500 participants
Enrollment target
8
Study locations

Study Summary

The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive or functional impairment.

Primary Outcome

This measure will determined by adding proportion of tract injury as measured by diffusion tensor imaging(DTI) methods. Measures are independent of the presenting Glasgow Coma Scale(GCS),ICH volume,location,age,sex and intraventricular hemorrhage (IVH).The primary outcome measure will be the global motor score from the motor assessment scale(MAS) testing which includes eight areas of assessment in eight areas of motor function.The MAS evaluates performance on functional tasks using a 7-point ord

Conditions Studied

Intracerebral Hemorrhage

Study Locations (8)

Illinois

  • University of Illinois Chicago - Chicago

Kentucky

  • Baptist Health Louisville - Louisville

Maryland

  • University of Maryland - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • Columbia University - New York

North Carolina

  • Duke University - Durham

Ohio

  • University of Cincinnati - Cincinnati

Texas

  • Houston Methodist - Houston

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-08-23
Est. Completion 2024-10-31
State University of New York at Buffalo

243 total trials

What the finished NCT04007757 record still lists

NCT04007757 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,090-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.

NCT04007757 lists 8 locations in 8 states (Illinois, Kentucky, Maryland).

Frequently Asked Questions

What is clinical trial NCT04007757 about?

NCT04007757 is a clinical study titled "Recovery and Outcomes From Stroke". The investigators will perform follow-up on 500 cases of deep and lobar intracerebral hemorrhage to perform advanced neuroimaging before 45 days post stroke, and evaluations of motor and cognitive function at baseline, 3 months and 6 months to determine predictors of recovery, progressive cognitive ...

What is the current status of trial NCT04007757?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2017-08-23. Estimated completion is 2024-10-31.

What conditions does trial NCT04007757 study?

This clinical trial studies the following conditions: Intracerebral Hemorrhage.

Who is sponsoring clinical trial NCT04007757?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04007757 being conducted?

This trial has 8 study locations across Illinois, Kentucky, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intracerebral Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04007757's enrollment target sits among peer trials

500 13th of 31 higher than 19 of 31 other Intracerebral Hemorrhage trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04007757, the US trial registry maintained by the National Library of Medicine. NCT04007757 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.